Drug Profile
Somatropin - Eli Lilly and Company
Alternative Names: Humatrope; Hutrope; LY 137998; UmatropeLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Developer Amylin Pharmaceuticals; Eli Lilly; Eli Lilly and Company
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cachexia; Growth disorders; Prader-Willi syndrome; Short bowel syndrome; Short stature; Somatotropin deficiency; Turner's syndrome
Most Recent Events
- 02 Oct 2012 Launched for Cachexia (in patients with AIDS) in India (SC) before October 2012
- 02 Oct 2012 Launched for Prader-Willi syndrome in Belgium (SC) before October 2012
- 02 Oct 2012 Launched for Prader-Willi syndrome in India (SC) before October 2012